---
title: "Polysaccharides in Pancreatic Cancer Therapy: Immunomodulation, Microbiota, Metabolic Routes"
id: "pubmed-42907040"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42907040"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42907040/"
doi: "10.1016/j.carbpol.2026.125917"
published_at: "2026-11-15T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Polysaccharides in Pancreatic Cancer Therapy: Immunomodulation, Microbiota, Metabolic Routes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42907040
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42907040/)
- **DOI:** [10.1016/j.carbpol.2026.125917](https://doi.org/10.1016%2Fj.carbpol.2026.125917)
- **Published At:** 2026-11-15T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Natural **polysaccharides** from plants, fungi, macroalgae, cyanobacteria and marine microbes have been reviewed for pancreatic cancer therapy; the review integrates in vitro, in vivo, and mechanistic studies. - The literature documents direct anti-tumor effects: proliferation inhibition; induction of apoptosis and ferroptosis; cell cycle arrest; metastasis suppression; and autophagy modulation. - Investigators reported immune effects including M1 macrophage polarization, natural killer cell activation, and enhanced cytotoxic T lymphocyte killing in preclinical models. - Data indicated microbiota-mediated benefits: enrichment of beneficial taxa, improved intestinal barrier integrity, increased short-chain fatty acids, and reduced lipopolysaccharide-driven inflammation. - The review identifies an axis linking gut microbiota regulation to systemic immune and metabolic outcomes, positioning the polysaccharide–gut microbiota interaction as an integrative hub. - Several characterized polysaccharides (> twenty named in the review) showed synergistic activity when combined with chemotherapeutic agents in preclinical work. - Structure–activity observations propose that low molecular weight, high galacturonic acid content, arabinose and galactose richness, and sulfation may correlate with activity; authors caution that robust attribution needs structurally defined molecules. - Major translational barriers remain: challenges in structural characterization, uncertain bioavailability, and lack of clinical validation, as the review emphasizes. - The evidence base consists largely of preclinical studies; the review consolidates mechanisms but notes the absence of definitive clinical trial data in the source material.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42907040/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42907040%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42907040/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42907040/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42907040/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42907040/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42907040/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42907040%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42907040%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42907040/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42907040/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42907040/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42907040/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Elsevier Science full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif) Elsevier Science ](https://linkinghub.elsevier.com/retrieve/pii/S0144-8617\(26\)01034-9 "See full text options at Elsevier Science") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42907040/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42907040/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42907040/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42907040/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42907040/#conflict-of-interest) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42907040/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42907040/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42907040/#substances) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42907040/#linkout) Title & authors Abstract Conflict of interest statement Publication types MeSH terms Substances LinkOut - more resources Review Carbohydr Polym Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Carbohydr+Polym%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Carbohydr+Polym%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) . 2026 Nov 15:392:125917. doi: 10.1016/j.carbpol.2026.125917. Epub 2026 Oct 7. # Natural polysaccharides in pancreatic cancer therapy: From immunomodulation and gut microbiota regulation to metabolic intervention [Da Lu](https://pubmed.ncbi.nlm.nih.gov/?term=Lu+D&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#full-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Ruitong Du](https://pubmed.ncbi.nlm.nih.gov/?term=Du+R&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#full-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Kang Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+K&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#full-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Lidong Guo](https://pubmed.ncbi.nlm.nih.gov/?term=Guo+L&cauthor_id=42907040)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#full-view-affiliation-2 "Department of Food Science and Engineering, Heilongjiang University of Chinese Medicine, China."), [Haixue Kuang](https://pubmed.ncbi.nlm.nih.gov/?term=Kuang+H&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#full-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Zhibin Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+Z&cauthor_id=42907040)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#full-view-affiliation-3 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China. Electronic address: wzbmailbox@163.com.") Affiliations Expand ### Affiliations * 1 Key Laboratory of Basic and Application Research of Beiyao (Ministry of Education), Heilongjiang University of Chinese Medicine, China. * 2 Department of Food Science and Engineering, Heilongjiang University of Chinese Medicine, China. * 3 Key Laboratory of Basic and Application Research of Beiyao (Ministry of Education), Heilongjiang University of Chinese Medicine, China. Electronic address: wzbmailbox@163.com. * PMID: **42907040** * DOI: [ 10.1016/j.carbpol.2026.125917 ](https://doi.org/10.1016/j.carbpol.2026.125917) Item in Clipboard Review # Natural polysaccharides in pancreatic cancer therapy: From immunomodulation and gut microbiota regulation to metabolic intervention Da Lu et al. Carbohydr Polym. 2026. Show details Display options Display options Format Abstract PubMed PMID Carbohydr Polym Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Carbohydr+Polym%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Carbohydr+Polym%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) . 2026 Nov 15:392:125917. doi: 10.1016/j.carbpol.2026.125917. Epub 2026 Oct 7. ### Authors [Da Lu](https://pubmed.ncbi.nlm.nih.gov/?term=Lu+D&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#short-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Ruitong Du](https://pubmed.ncbi.nlm.nih.gov/?term=Du+R&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#short-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Kang Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+K&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#short-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Lidong Guo](https://pubmed.ncbi.nlm.nih.gov/?term=Guo+L&cauthor_id=42907040)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#short-view-affiliation-2 "Department of Food Science and Engineering, Heilongjiang University of Chinese Medicine, China."), [Haixue Kuang](https://pubmed.ncbi.nlm.nih.gov/?term=Kuang+H&cauthor_id=42907040)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#short-view-affiliation-1 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China."), [Zhibin Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+Z&cauthor_id=42907040)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42907040/#short-view-affiliation-3 "Key Laboratory of Basic and Application Research of Beiyao \(Ministry of Education\), Heilongjiang University of Chinese Medicine, China. Electronic address: wzbmailbox@163.com.") ### Affiliations * 1 Key Laboratory of Basic and Application Research of Beiyao (Ministry of Education), Heilongjiang University of Chinese Medicine, China. * 2 Department of Food Science and Engineering, Heilongjiang University of Chinese Medicine, China. * 3 Key Laboratory of Basic and Application Research of Beiyao (Ministry of Education), Heilongjiang University of Chinese Medicine, China. Electronic address: wzbmailbox@163.com. * PMID: **42907040** * DOI: [ 10.1016/j.carbpol.2026.125917 ](https://doi.org/10.1016/j.carbpol.2026.125917) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Natural polysaccharides derived from plants, fungi, macroalgae, cyanobacteria, and other marine microorganisms have attracted increasing interest as adjuvant candidates for pancreatic cancer management due to their biocompatibility, structural diversity, and multi-target activities. This review consolidates current knowledge on their anti-pancreatic cancer activities, integrating findings from in vitro, in vivo, and mechanistic studies. We delineate the multi-level regulatory networks through which polysaccharides exert anti-tumor effects via four interconnected mechanisms: direct actions on cancer cells including proliferation inhibition, apoptosis and ferroptosis induction, cell cycle arrest, metastasis suppression, and autophagy modulation; immunomodulation via M1 macrophage polarization, natural killer cell activation, and cytotoxic T lymphocyte mediated killing; restoration of gut microbial homeostasis through beneficial taxa enrichment, intestinal barrier integrity enhancement, short-chain fatty acid elevation, and lipopolysaccharide driven inflammation reduction; and indirect tumor suppression by ameliorating obesity and type 2 diabetes mellitus. The polysaccharide gut microbiota axis emerges as a critical hub integrating these pathways. Structure-activity relationship analysis indicates that low molecular weight, high galacturonic acid content, arabinose and galactose richness, and sulfation may influence activity, although robust attribution requires structurally defined polysaccharides. More than twenty well characterized polysaccharides are documented, with several showing synergistic effects with chemotherapeutics. Despite encouraging preclinical evidence, challenges remain in structural characterization, bioavailability, and clinical validation. **Keywords:** Adjuvant therapy; Anti-tumor mechanism; Natural polysaccharides; Pancreatic cancer. Copyright © 2026 Elsevier Ltd. All rights reserved. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Antineoplastic Agents* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Agents%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Antineoplastic Agents* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Agents%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Antineoplastic Agents* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Agents%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Biological Products* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Biological+Products%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Biological+Products) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Biological Products* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Biological+Products%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Biological+Products) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Biological Products* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Biological+Products%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Biological+Products) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Gastrointestinal Microbiome* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gastrointestinal+Microbiome%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Gastrointestinal+Microbiome) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Immunomodulation* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Immunomodulation%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Immunomodulation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Pancreatic Neoplasms* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Pancreatic+Neoplasms%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Pancreatic+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Pancreatic Neoplasms* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Pancreatic+Neoplasms%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Pancreatic+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Pancreatic Neoplasms* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Pancreatic+Neoplasms%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Pancreatic+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Polysaccharides* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Polysaccharides%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Polysaccharides) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Polysaccharides* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Polysaccharides%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Polysaccharides) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42907040/) * Polysaccharides* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Polysaccharides%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://ww
## Related Clinical Research

- [Embolic Stroke and DOAC Failure in Libman-Sacks Endocarditis with Antiphospholipid Syndrome](https://medichelpline.com/clinical-feed/pubmed-43058350.md) (DOI: 10.1007/s00296-026-06331-w)
- [Macrophage HDAC3 and GDF3 Drive Adipose Inflammation and Metabolic Dysfunction](https://medichelpline.com/clinical-feed/pubmed-42731468.md) (DOI: 10.1016/j.intimp.2026.117385)
- [Metformin reduces metabolic and oxidative changes in a high-sucrose Drosophila model](https://medichelpline.com/clinical-feed/plos-one-13-metformin-modulates-survival-oxidative-stress-and-gene-expression-in-a-high.md)
- [Novo and Medicare’s Bridge program: what STAT reported and what wasn’t disclosed](https://medichelpline.com/clinical-feed/stat-news-1-stat-novo-may-be-getting-a-better-deal-than-expected-with-medicare-s-bridge.md)
- [Amylyx Presents Avexitide Results; MiniMed Launches Tubeless Insulin Pump](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-november-21-2026.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.